Abstract
Various blood safety initiatives have ensured a historically low risk of infection transmission through blood transfusion. Although further prevention of infection transmission is possible through, for example, nucleic acid testing and future introduction of pathogen inactivation, such initiatives are very costly in relation to the benefit they offer. Although estimation of the cost-effectiveness requires detailed information about the survival of transfusion recipients, previous cost-effectiveness analyses have relied on incorrect survival assumptions.
Original language | English |
---|---|
Journal | Transfusion |
Volume | 50 |
Issue number | 1 |
Pages (from-to) | 240-2 |
Number of pages | 3 |
ISSN | 0041-1132 |
DOIs | |
Publication status | Published - Jan 2010 |
Keywords
- Blood Banks
- Blood Transfusion
- Cost-Benefit Analysis
- Follow-Up Studies
- Humans
- Infection
- Infection Control
- Quality of Health Care
- Quality-Adjusted Life Years
- Risk Factors
- Scandinavia
- Survival Analysis